UK Gluck Publishes Phase One of Genetic Diversity Study

The first phase of a research study into the genetic diversity in Thoroughbreds is in the books, with researchers from the University of Kentucky's Gluck Center concluding from the phase one portion that diversity among Thoroughbreds “falls within the range for other breeds of horses” despite centuries of human intervention, according to the Gluck Center.

The study, by the Gluck Center's Ernie Bailey, PhD and Ted Kalbfleisch, PhD,, and Jessica Petersen, PhD, from the University of Nebraska-Lincoln, is based on sequencing the entire genome of Thoroughbred horses, and is published in the Equine Science Review of the University of Kentucky.

According to Dr. Bailey, the completion of their first phase of research in 2021 documents that the diversity among Thoroughbred horses is consistent with that found for other domestic animals and that it falls within the range for other breeds of horses.

In a press release Thursday, the team at Gluck called the study “the most comprehensive analysis of the genetics of the U.S. Thoroughbred to date. Previous studies of Thoroughbred diversity were based on sampling small subsets of the genome,” the release says.

“The goals of the study are to create a database that catalogs the variation across the genome of today's Thoroughbred horses and to generate anonymous (by horse) data that will create a foundation of knowledge for use in monitoring changes in genetic diversity over time,” they write.

During the first phase of the study, 1,000 Thoroughbred samples were collected from horses in Kentucky, California, Florida and New York. Pedigrees of the horses were examined and 120 were selected for whole-genome sequencing to capture as much of the genetic variation of the population as possible. As a result of sequencing these horses, the study aims to create a catalog of 15 million DNA variants among U.S. Thoroughbreds which can be used to monitor future changes in the Thoroughbred population as well as to construct computer models to assess how changes in breeding practices may affect the genetic structure of the population.

The second phase of research, now set to get underway, will be a sequencing project that aims to help protect the breed from deleterious recessive genes. The appearance of variants will be identified, and programs will be used to predict whether those variants might have a potentially negative effect on a gene. Additionally, the team is interested in using part of a survey of the whole breed to get at overall frequencies of genes.

“We can whole genome sequence every animal that is suspected of suffering from a deleterious recessive condition and look for possible causes; if none are proven we can archive the DNA in a database for comparison with future horses that appear with similar disease phenotypes,” Bailey said. “If we wait until a recessive deleterious disease occurs in 1% of the population, then 18% of all Thoroughbreds will already be carriers. This approach allows us to detect such genes before they become so prevalent.”

“Importantly,” the press release concludes, “these data will be publicly available so researchers at other institutions can perform studies of specific traits or genes. The genetic data, and the approach used in generating them, also represent a new tool available for breeders to use in maximizing the genetic potential of each foal and in ensuring the Thoroughbred's status as an elite population of equine athletes.”

Those interested in learning more about the project are invited to contact Dr. Bailey at ebailey@uky.edu. Those interested in supporting this project through financial contributions may contact Danielle Jostes at danielle.jostes@uky.edu.

The post UK Gluck Publishes Phase One of Genetic Diversity Study appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

UK Gluck to Develop Biological Passport

The Gluck Equine Research Foundation at the University of Kentucky is developing an equine biological passport with the goal of identifying specific biomarkers that will detect drug use by monitoring changes to peptides and protein abundance, and monitor those biomarkers over time, they announced Monday via press release.

In simple terms, an EBP would track biological changes in horses over time. Just like the one introduced by the World Anti-Doping Agency in 2009, an equine biological passport would use repeated blood samplings and use biomarkers to detect a horse’s reaction to performance-enhancing drugs as an alternative to traditional testing.

“The goals of this program are to elevate equine research at the University of Kentucky, to serve as a platform to impact policy change and drug testing protocol, and further understand the impact of drugs and medications on Thoroughbred racehorses,” said the release.

The release quoted Dr. Scott Stanley, the Director of UK’s Equine Analytical Chemistry Laboratory.

“In the last few years we have seen too many negative headlines around equine drug use,” said Stanley. “As a research scientist, with 30 years of regulatory drug testing experience, my team and I know this is a problem we cannot currently solve. We know that it takes time to develop new tests for each new emerging drug, so we will always be behind. We know that each horse metabolizes drugs at a different rate, making standard clearance and withdrawal times confusing. In addition, we know that there are environmental factors, human interactions, and hundreds of other variables that can impact our current drug testing procedures. The EBP program is a tool that will enable us to rapidly identify new drugs and measure the physiological effect on the equine athlete. These data will be critical in differentiating between intentional doping and accidental contaminants, which can smear the industry image and damage reputations.”

Stonestreet Farm announced they would be major participants in the funding of the program.

“At Stonestreet. we are proud of our integrity, our commitment to a level playing field and our focus on the health of the horse above all else,” said Stonestreet’s owner, Barbara Banke “An equine biological passport will give us a comprehensive program that provides full transparency for both competition and out-of-competition testing, for every stakeholder. Stonestreet will contribute $100,000 toward this project and I encourage all stakeholders, trainers and owners alike, to consider a tax-deductible gift as an investment in the future of the racing industry.”

The Equine Biological Passport program is an evolving research program, which is designed to expand and to be flexible enough to address new challenges, such as bio-therapeutics. Over the next several years, Gluck said they would continue to validate and refine the EBP program to position it as a future tool for the industry. In addition, it will provide scientific data needed to support changes in rules, and regulations that will allow us to prosecute violators and prevent `at risk’ horses from entering in competitions.

The Jockey Club has also thrown their financial support behind the project. “As part of our mission, The Jockey Club seeks new practices and methods to ensure a level playing field and often look for solutions that may have had success in human sports,” said Matt Iuliano, the Jockey Club’s Executive Vice President and Executive Director, who said they had been financially supporting Stanley’s EBP research for four years. “As such, The Jockey Club has a continuing effort to support research aimed at developing an equine biological passport. The EBP employs new analytical methods to detect the administration of substances that evade traditional drug testing testing. Because these substances cannot be directly tested, they pose a significant risk to health, safety and integrity in our sport. The EBP looks for changes in bio markers which signal when a substance was administered. The EBP is a huge step in rooting out cheaters.”

Gluck’s efforts would not be the first time the concept of a biological passport has been raised in racing.

The TDN’s T.D. Thornton has written several articles about the concept and the need for funding, including this effort at UC Davis in 2016. Stanley headed up that effort and brought his work with him to UK when he moved there in 2019.

“What we budgeted was $250,000 a year for five years to move it forward,” said Stanley. “That pays for personnel, development, computer time, and the data analysis that we need.”

For more information about this project, visit http://gluck.ca.uky.edu/content/equinebiological-passport, or contact Dr. Scott Stanley at scott.stanley2@uky.edu or 859.494.6319. Funding for this project is entirely dependent on private support. For more information on how to support this effort or to make a gift, contact Danielle Jostes at danielle.jostes@uky.edu or 502.641.6906.

The post UK Gluck to Develop Biological Passport appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights